DAPK1 mediates the G1 phase arrest in human nasopharyngeal carcinoma cells induced by grifolin, a potential antitumor natural product
Xiang-jian Luo , Wei Li , Li-fang Yang , Xin-fang Yu
European Journal of Pharmacology 670 ( 2) 427 -434
19
2011
Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells.
Xiang-jian Luo , Li-li Li , Qi-pan Deng , Xin-fang Yu
European Journal of Cancer 47 ( 2) 316 -325
77
2011
Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.
Ann M Bode , Min Tang , Ya Cao , Weihua Liao
Signal Transduction and Targeted Therapy 6 ( 1) 15
29
2021
Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
Longlong Xie , Feng Shi , Yueshuo Li , We Li
Signal Transduction and Targeted Therapy 5 ( 1) 56
11
2020
Grifolin directly targets ERK1/2 to epigenetically suppress cancer cell metastasis
Xiangjian Luo , Lifang Yang , Lanbo Xiao , Xiaofeng Xia
Oncotarget 6 ( 40) 42704 -42716
30
2015
Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis
Wenbin Liu , Wei Li , Haidan Liu , Xinfang Yu
International Journal of Biological Sciences 15 ( 11) 2497 -2508
47
2019
EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma.
Jingchen Lu , Min Tang , Hongde Li , Zhijie Xu
Cancer Letters 380 ( 1) 191 -200
45
2016
Corrigendum to “EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma” [Cancer Lett. 380 (1) (2016 Sep 28) 191–200]
Jingchen Lu , Min Tang , Hongde Li , Zhijie Xu
Cancer Letters 393 134
2017
Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis
Xinfang Yu , Wei Li , Zhenkun Xia , Li Xie
BMC Cancer 17 ( 1) 449 -449
29
2017
Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.
Xinfang Yu , Ruike Wang , Yangnan Zhang , Li Zhou
Oncogene 38 ( 50) 7457 -7472
25
2019
Regulation of microRNAs by epigenetics and their interplay involved in cancer
Xiaolan Liu , Xiaoyan Chen , Xinfang Yu , Yongguang Tao
Journal of Experimental & Clinical Cancer Research 32 ( 1) 96 -96
80
2013
Targeting PD-L1 in non-small cell lung cancer using CAR T cells.
Ming Liu , Xu Wang , Wei Li , Xinfang Yu
Oncogenesis 9 ( 8) 72 -72
29
2020
MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis.
Xinfang Yu , Wei Li , Qipan Deng , Haidan Liu
Blood 137 ( 12) 1615 -1627
1
2021
Isolation and Characterization of Aphidicolin and Chlamydosporol Derivatives from Tolypocladium inflatum
Jie Lin , Xiaoyan Chen , Xiaoyue Cai , Xinfang Yu
Journal of Natural Products 74 ( 8) 1798 -1804
14
2011
Repression of Noxa by Bmi1 contributes to deguelin-induced apoptosis in non-small cell lung cancer cells.
Wei Li , Xinfang Yu , Zhenkun Xia , Xinyou Yu
Journal of Cellular and Molecular Medicine 22 ( 12) 6213 -6227
14
2018
Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma
Xinfang Yu , Qi Liang , Wenbin Liu , Li Zhou
EBioMedicine 26 100 -111
31
2017
Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth.
Li Zhou , Xinfang Yu , Ming Li , Guanghui Gong
EBioMedicine 51 102570
43
2020
Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathway.
Ming Li , Xinfang Yu , Wei Li , Ting Liu
Oncotarget 9 ( 1) 152 -166
30
2018
MYD88 L265P Mutation in Lymphoid Malignancies.
Xinfang Yu , Wei Li , Qipan Deng , Ling Li
Cancer Research 78 ( 10) 2457 -2462
33
2018
Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination
Xiaolan Liu , Yueshuo Li , Songling Peng , Xinfang Yu
Cell Death & Disease 9 ( 2) 53 -53
31
2018